Gedea receives funding for microbiome research project with Centre for Translational Microbiome Research at Karolinska Institutet
Lund, Sweden, December 21, 2021. Swedish women’s health company Gedea Biotech today announced that it has received funding for a research project with the Centre for Translational Microbiome Research at Karolinska Institutet (KI), for its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV). The project goal is to better understand the microbial etiology of bacterial vaginosis (BV) and factors associated with successful, antibiotic-free treatment with pHyph.Bacterial vaginosis is one of the most common vaginal infections for women in childbearing age. The